Agilent Technologies and Proteome Systems Collaborate on Glycomics Solution; Integration of Agilent’s MS Technology, Proteome Systems’ Software to Help Scientists in Proteomics Research
Agilent Technologies Inc. and Proteome Systems, a leading international proteomics company, today announced they have signed a marketing agreement to collaborate on an integrated solution for the analysis of glycoproteins, molecules that are important in the study of many diseases, including cancer, influenza and arthritis. Under the agreement, Proteome Systems will make its GlycomIQ software, a comprehensive platform for the mass spectrometric analysis of protein-associated glycans (polysaccharides), compatible with the Agilent XCT, XCT Plus and XCT Ultra ion trap mass spectrometers.
Proteome Systems developed GlycomIQ to address the emerging field of glycomics, which examines how glycosylation, or the addition of sugars to proteins, affects biological processes and systems. GlycomIQ comprises kits, consumables and informatics software developed specifically for automated glycan analysis.
“Analysis of protein glycosylation is a demanding task that has often been reserved for specialized laboratories,” said Nicolle Packer, executive vice president and head of glycoproteomics of Proteome Systems. “The combination of Agilent’s robust, sensitive MS technology with our cutting-edge, automated glycomics system creates a powerful integrated solution that will streamline the study of glycoproteins.”
The co-marketed product is expected to be available this summer. Agilent and Proteome Systems will also collaborate on the development of applications and seminars as part of the marketing agreement.
“Agilent is proud of this collaboration with Proteome Systems,” said Taia Ergueta, general manager of Agilent’s Proteomics and LC/MS business. “It illustrates our ongoing commitment to making leading-edge life science research accessible to more scientists and more laboratories. Using Agilent’s protein separation and LC/MS products and Proteome Systems’ GlycomIQ software, life scientists will be better able to produce, analyze and integrate complex data on the forefront of proteomics research.”
About Proteome Systems
Proteome Systems’ Technology business develops and commercializes innovative technology solutions to enable proteomics and glycomics research. These solutions include integrated instrument-based systems, consumables and bioinformatic software. Proteome Systems’ Discovery & Diagnostics business discovers protein biomarkers that have potential for use as diagnostics and therapeutic targets in the areas of respiratory disease, neurobiology and aging and cancer. Additional information about Proteome Systems can be found at www.proteomesystems.com .
About Agilent Integrated Biology Solutions
Agilent Technologies is a leading supplier of life science research systems that enable scientists to understand complex biological processes, determine disease mechanisms and speed drug discovery. Engineered for sensitivity, reproducibility and workflow productivity, Agilent’s integrated biology solutions include instrumentation, microfluidics, software, microarrays, consumables and services for genomics, proteomics and metabolomics applications.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company’s 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com .
